Publications (272) Publications in which a researcher has participated

2024

  1. A Cross-Sectional Study to Assess the Knowledge of Pharmacy Students About Drug Pollution in Spain

    American Journal of Pharmaceutical Education, Vol. 88, Núm. 9

  2. A proposal to reduce the amount of permethrin entering wastewater resultant from topical use to treat scabies

    Science of the Total Environment

  3. Acetazolamide-induced pulmonary oedema: A disproportionality analysis from the EudraVigilance database

    British Journal of Clinical Pharmacology, Vol. 90, Núm. 7, pp. 1751-1755

  4. As We Were and As We Should Be, Combined Exercise Training in Adults With Schizophrenia: CORTEX-SP Study Part II

    Scandinavian Journal of Medicine and Science in Sports, Vol. 34, Núm. 8

  5. As We Were and as We Should Be, Combined Exercise Training in Adults with Schizophrenia: CORTEX-SP Study Part I

    Medicine and Science in Sports and Exercise, Vol. 56, Núm. 1, pp. 73-81

  6. Considering environmental impact of medicines in healthcare

    The Science of the total environment

  7. Empirical validity of Leonhard's psychoses: A long-term follow-up study of first-episode psychosis patients

    Schizophrenia Research, Vol. 263, pp. 237-245

  8. Functioning in schizophrenia: Recommendations of an expert panel

    Schizophrenia Research, Vol. 270, pp. 317-322

  9. Inappropriate prescribing in older people: not only a patient safety issue but an avoidable source of environmental harm

    Age and ageing

  10. Incorporating the One Health philosophy into pharmacovigilanc: Pharmacovigilance

    British Journal of Clinical Pharmacology

  11. Intranasal esketamine and manic symptoms: A disproportionality analysis in EudraVigilance

    European Neuropsychopharmacology

  12. Investigating the relationship between specific negative symptoms and metacognitive functioning in psychosis: A systematic review

    Psychology and Psychotherapy: Theory, Research and Practice, Vol. 97, Núm. 2, pp. 191-214

  13. Long-term trajectories of clinical staging in first-episode psychosis and their associated cognitive outcome: A 21-year follow-up study

    Spanish Journal of Psychiatry and Mental Health

  14. Medication impact on oral health in schizophrenia

    Medicina Oral Patologia Oral y Cirugia Bucal, Vol. 29, Núm. 1, pp. e51-e57

  15. Neuromotor dysfunction as a major outcome domain of psychotic disorders: A 21-year follow-up study

    Schizophrenia Research, Vol. 263, pp. 229-236

  16. Pharmaceutical residues in stranded dolphins in the Bay of Biscay

    Science of the Total Environment, Vol. 912

  17. Social exclusion as a major outcome domain of psychotic disorders: early predictors, and associations with non-recovery and clinical staging 21 years after a first episode of psychosis

    Social Psychiatry and Psychiatric Epidemiology

  18. Terapia metacognitiva interpersonal en los trastornos de la personalidad

    Tratamientos psicológicos en los trastornos de la personalidad: adaptado al DSM-5-TR y a la CIE-11 (Pirámide), pp. 81-94

  19. The association of adverse childhood experiences with long-term outcomes of psychosis: a 21-year prospective cohort study after a first episode of psychosis

    Psychological Medicine

  20. The urgent need for designing greener drugs

    Nature Sustainability